사용금지 화장품 물질 — 부속서 II
부속서 II는 화장품 원료로 의도적으로 첨가하는 것이 금지된 물질을 나열합니다. 제17조는 별도로, 우수화장품제조관리기준(GMP)과 제3조의 안전 요건에 따라 기술적으로 피할 수 없는 비의도적 미량을 다룹니다. 이 페이지에는 기록 1739건이 있습니다.
이 부속서 필터링
이 부속서의 구성
Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.
- 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
- Prohibition covers intentional addition; there is no permitted concentration.
- Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
- Absence from Annex II is not permission — most substances appear in no annex at all.
Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.
The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.
Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.
The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.
대조 대상
부속서 II 기록
1739 총| 항목 | 물질 | CAS | 최대 농도 | 표시 |
|---|---|---|---|---|
| 1578 | ParaformaldehydeCAS 30525-89-4 | 30525-89-4 | — | CMR |
| 1579 | Methanediolmethylene glycolCAS 463-57-0 | 463-57-0 | — | |
| 1580 | cymoxanil (ISO)2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [1]/ (2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [2]CAS 57966-95-7 / 166900-80-7 | 57966-95-7 / 166900-80-7 | — | CMR |
| 1581 | Tributyltin compounds | — | — | CMR |
| 1582 | Tembotrione (ISO)2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dioneCAS 335104-84-2 | 335104-84-2 | — | CMR |
| 1583 | 1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linearCAS 68515-50-4 | 68515-50-4 | — | CMR |
| 1584 | Spirotetramat (ISO)(5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonateCAS 203313-25-1 | 203313-25-1 | — | CMR |
| 1585 | Dodemorph acetate4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetateCAS 31717-87-0 | 31717-87-0 | — | CMR |
| 1586 | Triflusulfuron-methylmethyl 2-({[4-(dimethylamino)-6-(2,2,2- trifluoroethoxy)-1,3,5-triazin-2- yl]carbamoyl}sulfamoyl)-3- methylbenzoateCAS 126535-15-7 | 126535-15-7 | — | CMR |
| 1587 | Imazalil (ISO)1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazoleCAS 35554-44-0 | 35554-44-0 | — | CMR |
| 1588 | Dodemorph (ISO)4-cyclododecyl-2,6-dimethylmorpholineCAS 1593-77-7 | 1593-77-7 | — | CMR |
| 1589 | ImidazoleCAS 288-32-4 | 288-32-4 | — | CMR |
| 1590 | Lenacil (ISO)3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dioneCAS 2164-08-1 | 2164-08-1 | — | CMR |
| 1591 | Metosulam (ISO)N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamideCAS 139528-85-1 | 139528-85-1 | — | CMR |
| 1592 | 2-Methyl-1-(4-methylthiophenyl)-2-morpholino-propan 1-oneCAS 71868-10-5 | 71868-10-5 | — | CMR |
| 1593 | 2,3-Epoxypropyl methacrylateglycidyl methacrylateCAS 106-91-2 | 106-91-2 | — | CMR |
| 1594 | Spiroxamine (ISO)8-tert-butyl-1,4-dioxaspirol[4.5]decan-2-ylmethyl(ethyl)(propyl)amineCAS 118134-30-8 | 118134-30-8 | — | CMR |
| 1595 | CyanamidecarbanonitrilCAS 420-04-2 | 420-04-2 | — | CMR |
| 1596 | Cyproconazole (ISO)(2RS,3RS; 2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-olCAS 94361-06-5 | 94361-06-5 | — | CMR |
| 1597 | Silver zinc zeoliteCAS 130328-20-0 | 130328-20-0 | — | CMR |
| 1598 | Cadmium carbonateCAS 513-78-0 | 513-78-0 | — | CMR |
| 1599 | Cadmium hydroxidecadmium dihydroxideCAS 21041-95-2 | 21041-95-2 | — | CMR |
| 1600 | Cadmium nitratecadmium dinitrateCAS 10325-94-7 | 10325-94-7 | — | CMR |
| 1601 | Dibutyltin dilauratedibutyl[bis(dodecanoyloxy)] stannaneCAS 77-58-7 | 77-58-7 | — | CMR |
| 1602 | Clorofenechlorophene; 2-benzyl-4-chlorophenolCAS 120-32-1 | 120-32-1 | — | CMR |
| 1603 | Anthraquinone9,10-anthraquinoneCAS 84-65-1 | 84-65-1 | — | CMR |
| 1604 | Nonadecafluorodecanoic acid [1]Ammonium nonadecafluorodecanoate [2]; Sodium nonadecafluorodecanoate [3]CAS 335-76-2[1] 3108-42-7[2] 3830-45-3[3] | 335-76-2[1] 3108-42-7[2] 3830-45-3[3] | — | CMR |
| 1605 | N,N'-MethylenedimorpholineN,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/wCAS 5625-90-1 | 5625-90-1 | — | CMR |
| 1606 | Reaction products of paraformaldehyde with 2-hydroxypropylamine (3:2)[formaldehyde released from 3,3'-methylenebis[5–methyloxazolidine]; [formaldehyde released from oxazolidin]; [MBO] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w | — | — | |
| 1607 | Reaction products of paraformaldehyde with 2-hydroxypropylamine (1:1))[formaldehyde released from a,a,a-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w | — | — | |
| 1608 | MethylhydrazineCAS 60-34-4 | 60-34-4 | — | CMR |
| 1609 | Triadimenol (ISO)(1RS,2RS; 1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; a-tert-butyl-ß-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanolCAS 55219-65-3 | 55219-65-3 | — | CMR |
| 1610 | Thiacloprid (ISO)(Z)-3-(6-chloro-3-pyridyl-methyl)-1-3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamideCAS 111988-49-9 | 111988-49-9 | — | CMR |
| 1611 | Carbetamide (ISO)(R)-1-(ethylcarbamoyl) ethyl-carbanilate; (2R)-1-(ethylamino) -1-oxopro-pan-2-yl-phenylcarbamateCAS 16118-49-3 | 16118-49-3 | — | CMR |
| 1612 | Phosmet (ISO)S-[(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)methyl]-O,O-dimethyl phosphorodithioate; O,O-dimethyl-S-phthalimidomethyl phosphorodithioateCAS 732-11-6 | 732-11-6 | — | CMR |
| 1613 | Potassium permanganateCAS 7722-64-7 | 7722-64-7 | — | CMR |
| 1614 | 2-Benzyl-2-dimethylamino-4'- morpholinobutyrophenoneCAS 119313-12-1 | 119313-12-1 | — | CMR |
| 1615 | Quizalofop-p-tefuryl (ISO)(+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2-yloxy)phenyloxy]propionateCAS 200509-41-7 | 200509-41-7 | — | CMR |
| 1616 | Propiconazole (ISO)(2RS,4RS; 2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4-triazoleCAS 60207-90-1 | 60207-90-1 | — | CMR |
| 1617 | Pinoxaden (ISO)8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoateCAS 243973-20-8 | 243973-20-8 | — | CMR |
| 1618 | Tetramethrin(1-Cyclohexene-1,2-Dicarboximido)Methyl Chrysanthemate; 2,2-Dimethyl-3-(2-Methyl-1-Propenyl)Cyclopropanecarboxylic Acid (1,3,4,5,6,7-Hexahydro-1,3-Dioxo-2H-Isoindol-2-yl)Methyl EsterCAS 7696-12-0 | 7696-12-0 | — | CMR |
| 1619 | (1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylateCAS 1166-46-7 | 1166-46-7 | — | CMR |
| 1620 | Spirodiclofen (ISO)3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrateCAS 148477-71-8 | 148477-71-8 | — | CMR |
| 1621 | Reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamineCAS 897393-42-9 | 897393-42-9 | — | CMR |
| 1622 | 1-VinylimidazoleCAS 1072-63-5 | 1072-63-5 | — | CMR |
| 1623 | Amisulbrom (ISO)3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamideCAS 348635-87-0 | 348635-87-0 | — | CMR |
| 1624 | Pirimicarb (ISO)2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamateCAS 23103-98-2 | 23103-98-2 | — | CMR |
| 1625 | 1,2-Dichloropropanepropylene dichlorideCAS 78-87-5 | 78-87-5 | — | CMR |
| 1626 | Phenol, dodecyl-, branched [1]Phenol, 2-dodecyl-, branched [2]; Phenol, 3-dodecyl-, branched [3]; Phenol, 4-dodecyl-, branched [4]; Phenol, (tetrapropenyl) derivatives [5]CAS 121158-58-5[1]; 1801269-80-6[2] ; 1801269-77-1[3]; 210555-94-5[4]; 74499-35-7[5] | 121158-58-5[1]; 1801269-80-6[2] ; 1801269-77-1[3]; 210555-94-5[4]; 74499-35-7[5] | — | |
| 1627 | Coumatetralyl (ISO)4- hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl) coumarinCAS 5836-29-3 | 5836-29-3 | — | CMR |
이 그룹별 보기 사용 방법
부속서 II에는 화장품에 사용이 금지된 물질이 포함되어 있습니다. 사용금지 물질 기록 1739건을 명칭, 식별자 및 연결된 항목 페이지별로 빠르게 훑어보려면 이 그룹별 보기를 이용하세요.
법적 문구 전문, 농도 논리, 경고 문구 또는 관련 식별자 링크가 필요하면 개별 기록을 여세요.